MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0004537
Midas Care Pharmaceuticals Pvt Ltd - fmcg in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹139.99 Cr
▲ 3% YoY
Net profit · FY 2025
₹24.4 Cr
Net margin 17.4%
EBITDA · FY 2025
₹30 Cr
EBITDA margin 21.4%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹6.09 Lakh
Issued & subscribed
Open charges
₹15 Cr
Satisfied ₹138.39 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
413
Provident fund records
About Midas Care Pharmaceuticals Pvt Ltd
Data last updated:
Midas Care Pharmaceuticals Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Midas Care Holdings Pvt Ltd. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 16 May 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1986PTC039852. Its GSTIN is 27AAACM4264B1ZU (Maharashtra). The company holds 11 GST registrations, of which 7 are active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹6.09 Lakh. It is led by directors including Sangithaa Gupta Brijbandhu (Managing Director) and Nandan Brijbandhu Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Lotus Corporate Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹139.99 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹24.4 Cr (net margin 17.4%) and EBITDA of ₹30 Cr (EBITDA margin 21.4%). Revenue has declined at a compounded annual rate (CAGR) of 3% over five years.
The company has about 413 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Midascare. As per MCA filings, the company has open charges of ₹15 Cr and satisfied charges of ₹138.39 Cr on record. Court records list 81 cases involving the company, including 61 filed by the company and 20 filed against it; 12 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹3.1 Lakh; the latest was in March 2020. Its 4 peer companies in the Packaging industry (Bottles and Caps, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Ratnatris Pharmaceuticals Private Limited with revenue of ₹141.71 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2020, listing 58 overdue payments to 5 micro and small suppliers.
Midas Care Pharmaceuticals Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0004537). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website midas-care.com.
Company details
CIN U24239MH1986PTC039852
Registration Number 039852
Incorporation Date 16 May 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Midas Care Holdings Pvt Ltd
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0004537
Key People
Sangithaa Gupta Brijbandhu Managing Director Nandan Brijbandhu Gupta Director Shivangi Gupta Director Recognitions & Rankings of Midas Care Pharmaceuticals
Contact details
Midas Care Pharmaceuticals Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is midas-care.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressLotus Corporate Park B Wing 3rd Floor Graham Firth Comp. Near W E Highway Go, Regaon(E), Mumbai, Maharashtra, India – 400063
- IndustryFMCG, Personal Care & Skincare Products, Home Care & Cleaning Products
To see the full contact details of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Midas Care Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Midas Care Pharmaceuticals operates one associated brand: Midascare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical products for healthcare, personal, home, and auto care in India. | midas-care.com |
Business activity
The main business activity of Midas Care Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Midas Care Pharmaceuticals Pvt Ltd
FY 2024 filings availableMidas Care Pharmaceuticals Pvt Ltd reported revenue of ₹139.99 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹139.99 Cr ▲ 3%
Net profit · FY 2025
₹24.4 Cr margin 17.4%
EBITDA · FY 2025
₹30 Cr margin 21.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 203%
3 years · compounded
▲ 55%
5 years · compounded
▲ 12%
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 203% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.4% | ||||
| Net Profit Margin | 17.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Midas Care Pharmaceuticals Pvt Ltd
Midas Care Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandan Brijbandhu Gupta Also directs: Lovincare Cosmetics Private Limited | Director | 01 Mar 2011 | 15 Years 8 Months | Current |
| Shivangi Gupta Also directs: Florensa Care Products LLP, Lovincare Cosmetics Private Limited | Director | 21 Oct 2005 | 21 Years 0 Months | Current |
| Sangithaa Gupta Brijbandhu Also directs: Florensa Care Products LLP, Lovincare Cosmetics Private Limited | Managing Director | 15 Sep 1986 | 40 Years 1 Months | Current |
Peer comparison
Midas Care Pharmaceuticals Pvt Ltd is compared with the 4 companies closest to it by revenue in the Packaging industry (Bottles and Caps, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | 35.0% | Ahmedabad, Gujarat, India | |||
| Midas Care Pharmaceuticals Pvt Ltdthis company | ₹139.99 Cr (FY 2025) | ₹24.4 Cr | 17.4% | 3.0% | 413 | Mumbai, Maharashtra, India |
| Ontop Pharmaceuticals Private Limited | ₹138.93 Cr (FY 2024) | 4.0% | Hosur Road, Bangalore, Karnataka, India | |||
| Satyadeeptha Pharmaceuticals Limited | ₹138.74 Cr (FY 2025) | -31.0% | Humnabad, Karnataka, India | |||
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | 10.0% | Bidar, Karnataka, India |
To see the full peer comparison of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Midas Care Pharmaceuticals Pvt Ltd is audited by Mehta Chokshi And Shah for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mehta Chokshi And Shah | FY 2024 | 10620W |
Shareholding
The shareholding of Midas Care Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹15 Cr
Satisfied charges
₹138.39 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Aug 2025 | 101157605 | Hdfc Bank Limited | ₹15 Cr | Open | |
| 29 Sep 2017 | 100141198 | Hdfc Bank Limited | ₹7.3 Cr | Satisfied | |
| 18 Sep 2013 | 10458591 | Icici Bank Limited | ₹14.5 Cr | Satisfied | |
| 28 Nov 2011 | 10325152 | Deutsche Bank Ag | ₹2.5 Cr | Satisfied | |
| 16 Oct 2008 | 10131253 | Hdfc Bank Limited | ₹50.25 Cr | Satisfied |
To see the full charge records of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Midas Care Pharmaceuticals Pvt Ltd has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹3.1 Lakh; the latest was in March 2020.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹3.1 Lakh
Deals on record (2 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2015 | Secondary share transfer | Undisclosed | Seller: 3 individuals |
To see the full deal history of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Midas Care Pharmaceuticals Pvt Ltd has 81 court cases on record: 61 filed by Midas Care Pharmaceuticals, 20 filed against it. 12 cases are pending and 69 are disposed.
Total cases
81
Filed by the company
61
Filed against the company
20
Pending
12
Disposed
69
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 67 | 19 | 10 |
| High courts | 14 | 1 | 2 |
Cases on record (5 of 81)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Maharashtra State Electricity Distribution Company Limited and 1 other | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed against the company by Miss Cherie Cosmetics Pvt Ltd | Disposed |
| District court, Aurangabad, Maharashtra | Civil suit | Filed against the company by State of Maharashtra | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (COMPLAINT ULP) | Filed against the company by an individual | Pending |
| High Court of Delhi | Appeal | Filed by the company against Employees State Insurance Corporation & Ors. | Pending |
To see the full case history of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Midas Care Pharmaceuticals Pvt Ltd has 3 MSME Form 1 returns on record between 2019 and 2020, listing 58 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
To see the full MSME payment records of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Midas Care Pharmaceuticals Pvt Ltd has a workforce of 413 employees on its EPFO records as of Feb 28, 2025, across 4 active EPFO establishments.
Employee count
413
Active EPFO establishments
4
Employee growth
-4.62%
GST
Midas Care Pharmaceuticals has 11 GST registrations: 7 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
11
Active
7
Cancelled / inactive
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM4264B1ZU | Maharashtra | Active | 01 Jul 2017 |
| 27AAACM4264B2ZT | Maharashtra | Active | 31 Jul 2020 |
| 02AAACM4264B2Z5 | Himachal Pradesh | Active | 01 Jul 2017 |
| 07AAACM4264B1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Midas Care Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Midas Care Pharmaceuticals Pvt Ltd has 3 board changes on record since 1986: 3 appointments. The latest: Nandan Brijbandhu Gupta was appointed as Director on 01 Mar 2011.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,500.00 Lakh with Charge ID 101157605 was registered on 16 Aug 2025.
AGM
Midas Care Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Midas Care Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 18 Sep 2013 via Charge ID 10458591 with Icici Bank Limited was fully satisfied on 24 Dec 2020.
Charges
A charge registered on 29 Sep 2017 via Charge ID 100141198 with Hdfc Bank Limited was fully satisfied on 07 Aug 2020.
Charges
A charge registered on 16 Oct 2008 via Charge ID 10131253 with Hdfc Bank Limited was fully satisfied on 07 Aug 2020.
Charges
A charge registered on 24 Jul 2007 via Charge ID 10067022 with Hdfc Bank Limited was fully satisfied on 07 Aug 2020.
Charges
A charge registered on 28 Nov 2011 via Charge ID 10325152 with Deutsche Bank Ag was fully satisfied on 03 Mar 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 730.00 Lakh with Charge ID 100141198 was registered on 29 Sep 2017.
Charges
A charge with Hdfc Bank Limited of Rs. 6,205.00 Lakh registered on 24 Jul 2007 with Charge ID 10067022 was modified on 12 Apr 2017.
Charges
A charge with Icici Bank Limited of Rs. 1,450.00 Lakh registered on 18 Sep 2013 with Charge ID 10458591 was modified on 16 Jul 2014.
Charges
A charge with Hdfc Bank Limited of Rs. 5,025.00 Lakh registered on 16 Oct 2008 with Charge ID 10131253 was modified on 15 Jul 2014.
20 earlier events are in the company report.
Frequently asked questions
Midas Care Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 16 May 1986 (40+ years old) and is registered under CIN U24239MH1986PTC039852.
Midas Care Pharmaceuticals has 3 current directors:
- Sangithaa Gupta Brijbandhu - Managing Director
- Nandan Brijbandhu Gupta - Director
- Shivangi Gupta - Director
The latest financial statements of Midas Care Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Midas Care Pharmaceuticals is 27AAACM4264B1ZU, registered in Maharashtra. The company has 11 GST registrations in all, of which 7 are active and 4 are cancelled or inactive. Other active GSTINs include 27AAACM4264B2ZT (Maharashtra), 02AAACM4264B2Z5 (Himachal Pradesh), 07AAACM4264B1ZW (Delhi).
The CIN (Corporate Identification Number) of Midas Care Pharmaceuticals is U24239MH1986PTC039852. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Midas Care Pharmaceuticals has 81 court cases on record: 61 filed by the company and 20 filed against it. 12 are pending. Most are in the district courts.
Midas Care Pharmaceuticals was incorporated on 16 May 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.
Midas Care Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹3.1 Lakh; the latest was in March 2020.
The peers of Midas Care Pharmaceuticals by revenue are Ratnatris Pharmaceuticals Private Limited, Ontop Pharmaceuticals Private Limited, Satyadeeptha Pharmaceuticals Limited, Corvine Chemicals and Pharmaceuticals Private Limited, all in the Packaging industry (Bottles and Caps, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nandan Brijbandhu Gupta was appointed as Director on 01 Mar 2011. Shivangi Gupta was appointed as Director on 21 Oct 2005. Sangithaa Gupta Brijbandhu was appointed as Managing Director on 15 Sep 1986.
Yes, Midas Care Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0004537).
Midas Care Pharmaceuticals has 3 MSME Form 1 returns on record between 2019 and 2020, listing 58 overdue payments to 5 micro and small suppliers. The latest return was filed on 04 Oct 2020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages